Home > Healthcare > Digital Therapeutics Market > Table of Contents

Digital Therapeutics Market - By Component (Software, Device), By Application (Diabetes, Obesity, Cardiovascular, Mental & Behavioural Health, Hypertension, Insomnia), By Sales Channel (B2B, B2C), By Region - Global Forecast to 2032

  • Report ID: GMI5408
  • Published Date: Nov 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Increasing prevalence of chronic diseases

3.2.1.2    Rising need for cost containment

3.2.1.3    Potential to increase quality of care delivery

3.2.2.4    Growing popularity of digital therapeutics

3.2.2    Industry pitfalls & challenges

3.2.2.1    Security and privacy issues

3.2.2.2    Lack of skilled IT professionals

3.3    Growth potential analysis

3.3.1    By component

3.3.2    By application

3.3.3    By sales channel

3.4    Regulatory landscape

3.4.1    U.S.

3.4.2    Europe

3.5    Technological landscape

3.5.1    Core technologies

3.5.2    Adjacent technologies

3.6    Future market trends

3.7    Gap analysis

3.8    Porter’s analysis

3.9    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Company matrix analysis

4.4    Competitive analysis of major market players

4.5    Competitive positioning matrix

4.6    Strategy dashboard

Chapter 5   Market, By Component, 2018 - 2032 (USD Million)

5.1    Key trends

5.2    Software

5.3    Device

Chapter 6   Market, By Application, 2018 – 2032 (USD Million)

6.1    Key trends

6.2    Diabetes

6.3    Obesity

6.4    Cardiovascular

6.5    Mental & behavioral health

6.6    Hypertension

6.7    Insomnia

6.8    Others

Chapter 7   Market, By Sales Channel, 2018 – 2032 (USD Million)

7.1    Key trends

7.2    Business-to-business (B2B)

7.3    Business-to-consumers (B2C)

Chapter 8   Market, By Region, 2018 – 2032 (USD Million)

8.1    Key trends

8.2    North America

8.2.1    U.S.

8.2.2    Canada

8.3    Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Spain

8.3.5    Italy

8.4    Asia Pacific

8.4.1    Japan

8.4.2    China

8.4.3    India

8.4.4    Australia

8.5    Latin America

8.5.1    Brazil

8.5.2    Mexico

8.6    MEA

8.6.1    South Africa

8.6.2    Saudi Arabia

Chapter 9   Company Profiles

9.1   Otsuka Holdings Co., Ltd

9.2   LifeScan Inc.

9.3   Teladoc Health

9.4   Omada Health Inc.

9.5   Pear Therapeutics, Inc.

9.6   Propeller Health (ResMed)

9.7   Teladoc Health

 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 7
  • Tables & Figures: 209
  • Countries covered: 17
  • Pages: 169
 Download Free Sample